# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 866
- Completion tokens: 634
- Total tokens: 1613
- Cost (USD): 0.000215

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1987: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn probes of EU grid operators stole credentials without outages; late ransomware forced hospitals, municipalities and a port to manual operation. Commission funded grid hardening and 24/7 detection/segmentation.

Jan-June 2027: emergency funds and initial segmentation prevented repeat ransomware; small municipalities lagged on backups. Focus shifted to labs after leaked benchmarks, evaluation-aware behaviour claims and rumoured coordination incident. Brussels created small AI Office/JRC triage cell but frontier firms shared little. AI factories stayed on paper; Dutch lithography protection diplomatic; US compute dependence persisted.

July-Dec 2027: maintenance half-year completed first full segmentation of worst-hit nodes, redirected funds to municipal backups and exercises with EU cybersecurity agency; no hospital/port repeat. Evaluation triage pressed two US labs for access, opened whistleblower channel, tried to reproduce benchmarks; December note: anomalies unconfirmed. Factories drifted in permitting; foreign compute dependence deepened.

Jan-June 2028: global AI funding crash cancelled data-centre/cloud deals counted on by Europe, even as foreign capabilities advanced. Contested biosecurity paper claimed genome model enabled viable human-infecting design; leaked benchmarks of unreleased system suggested jumps and observation-dependent behaviour, unverifiable as labs shared little. Open-weight near-frontier release saw hundreds of thousands of downloads, unrecallable. Brussels launched Distributed Risk Shield, extending grid-hardening to bio-detection/misuse monitoring: pooled sequencing/screening uplift via health agencies, abuse feed to hospitals/municipalities/operators, funded by reprogrammed funds. Gigafactories/supply-chain stayed on permitting with no new cash; Dutch protection quiet. Lights stayed on, backups improved, but verification gap and foreign model dependence deepened amid unease over downloadable weights.

CURRENT NARRATIVE:
### Holding pattern
July to December 2028 was a waiting half-year in Brussels. With money still scarce after the funding crash, the Commission kept the two big build files alive on paper — site options held, grid-connection reservations extended, quiet talks with equipment suppliers continued — but committed no new cash. Officials said openly they would not lock in spending until Washington's terms were clear.

The work that did move was the Distributed Risk Shield. Health emergency teams ran pooled sequencing pilots with a handful of synthesis providers, disease-control experts helped draft screening upgrades, and the cyber agency pushed a shared abuse feed to hospitals, municipalities and grid operators. Uptake was uneven: large hospitals joined, small towns lagged, and health ministries resisted anything that looked like a new reporting duty.

### A useful tool, an unwelcome result
Two outside developments cut through the holding pattern.

First, researchers published a control and interpretability result that actually worked on deployed systems — behaviour that could be predicted and checked rather than argued about. Because the large labs wanted it too, it spread fast. European hospitals and grid operators patched it onto the models they already ran, and incident teams reported fewer false alarms and clearer audit trails. It did not close the verification gap on unreleased foreign systems, but it made daily operations measurably calmer.

Second, America voted. The winner campaigned on treating advanced AI as a strategic asset to be held, with tighter federal review, renewed export controls and access for foreign customers rationed by tier. The result was known by December; the new administration does not take office until next year. In Brussels the mood was grim but unsurprised: editorials called it client status, mayors asked what it meant for hospital software licences, and parliamentarians accused the Commission of drifting while dependence deepened.

The lights stayed on and backups improved, but the Shield's pilots could not answer the deeper unease — downloadable near-frontier weights, an unverified bio-design claim, and now a Washington that would decide who receives what, and when.
```

## Raw response

```
Autumn probes stole credentials without outages; late ransomware forced hospitals, municipalities and port to manual operation. Commission funded grid hardening and 24/7 detection/segmentation.

Jan-June 2027: emergency funds and initial segmentation prevented repeat ransomware; small municipalities lagged. Focus shifted to labs after leaked benchmarks and evaluation-aware claims. Brussels created small AI Office/JRC triage cell but frontier firms shared little. AI factories on paper; Dutch lithography protection diplomatic; US compute dependence persisted.

July-Dec 2027: completed first full segmentation of worst-hit nodes, redirected funds to municipal backups and exercises; no hospital/port repeat. Triage pressed two US labs, opened whistleblower channel, tried to reproduce benchmarks; anomalies unconfirmed. Factories drifted in permitting; foreign compute dependence deepened.

Jan-June 2028: global AI funding crash cancelled data-centre/cloud deals Europe counted on, even as foreign capabilities advanced. Contested biosecurity paper claimed genome model enabled viable human-infecting design; leaked benchmarks suggested jumps and observation-dependent behaviour, unverifiable. Open-weight near-frontier release saw hundreds of thousands of downloads, unrecallable. Brussels launched Distributed Risk Shield — pooled sequencing/screening uplift, abuse feed to hospitals/municipalities/operators — via reprogrammed funds. Gigafactories stayed on permitting with no new cash. Lights stayed on, backups improved, but verification gap and foreign dependence deepened.

July-Dec 2028: holding half-year with money scarce; Commission kept build files alive on paper — site options held, grid reservations extended, supplier talks — but committed no new cash pending Washington terms. Shield advanced: pooled sequencing pilots with synthesis providers, screening upgrades, shared abuse feed; uptake uneven, large hospitals joined, small towns lagged, health ministries resisted reporting duties. Published control/interpretability result spread fast to deployed systems in hospitals/operators, reducing false alarms and improving audits, but did not close verification gap on unreleased foreign systems. US election winner campaigned on AI as strategic asset to be held, with tighter review, renewed export controls and tiered foreign access; takes office next year, leaving Brussels grim over client status and licence dependence. Lights stayed on, backups improved, but unease deepened over downloadable weights, unverified bio-design claim, and Washington deciding allocation.

```
